- Lobbying
- Emily AND Felder
Lobbying Arrangements Results for 'Emily Felder'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues related to the HIV/STD community viral hepatitis funding Appropriations Issues related to COVID-19 relief H.R. 5376 - Build Back Better Act |
NMAC (on behalf of the HIV/STD Partnership)
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Rural healthcare coverage and reimbursement Student loan repayment Public Health Emergency policies and funding Competition issues Healthcare workforce and staffing issues |
LifePoint Health
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, National Defense Authorization Act. Appropriations bills (FDA, Labor, HHS). Recognizing pharmacists as providers ... |
Cencora, Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to the development and approval of therapies for rare diseases |
Harmony Biosciences
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to the individual marketplace Health insurance tax and general tax issues Part D Issues related to Medicare Advantage H.R.2166 - Ensuring Parity in MA and PACE for Audio-Only Telehea... |
Anthem, Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Visa Processing Improvement Act (S.2632) Visitor Visa Wait Time Reduction Act (H.R.5127) International travel issues International visa processing issues/ appropriations Pandemic risk insurance iss... |
Exhibitions & Conferences Alliance
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to diagnostic testing and reimbursement related to COVID testing Issues related to the Strategic National Stockpile, supply chain, and future pandemic preparedness PREVENT Pandemics... |
Cepheid
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Pharmacist provider status Issues related to drug pricing Implementation of the Inflation Reduction Act of 2022 Issues related to access and distribution of pharmaceutical products |
Walgreen Co.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to drug discovery, drug development, vaccine technologies, and coverage and reimbursement Issues related to international vaccine deployment |
ModernaTX, Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutic... |
Novartis
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to Patent reform Implementation of Inflation Reduction Act of 2022 HELP Copays Act |
ABBVIE
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to scientific, technical, and medical publications Open access language in all appropriations and authorization bills Privacy Issues American Data Privacy and Pr... |
RELX Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Telemedicine Availability of medical products Issues related to surgical bleed management H.R.5376 - Build Back Better Act H.R.4809/S.2025 - Patient Access to ESRD New Innovative Devices Act Issue... |
Baxter HealthCare Corporation
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to patient access Issues related to patents Legislation related to competition and intellectual property issues Issues related to corporate and international tax issues; Issues relat... |
JOHNSON & JOHNSON SERVICES, INC.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP |